Showing 141 - 160 results of 2,085 for search '"Viral hepatitis"', query time: 0.12s Refine Results
  1. 141

    CHRONIC VIRAL HEPATITIS, TUBERCULOSIS, AND HIV AS COMORBIDITY: FROM THEORY TO PRACTICE by V. V. Nechaev, A. K. Ivanov, A. A. Sacra, E. S. Romanova, L. V. Lyalina, L. N. Pozhidaeva

    Published 2018-01-01
    “…Among the chronic viral hepatitis in the first and second periods were dominated by chronic viral hepatitis C (of 28,1 and 39,8%), and in the third period came to dominate the hepatitis caused by combination viruses B and C (58,8 per cent). …”
    Get full text
    Article
  2. 142

    FEATURES OF CELLULAR AND HUMORAL IMMUNITY IN ACUTE AND CHRONIC VIRAL HEPATITIS В by A. G. Borisov, A. A. Savchenko

    Published 2012-05-01
    “…It is established that changing the values of immunological parameters can determine the nature of the infection couse in chronic viral hepatitis B and select at least two types of immune response. …”
    Get full text
    Article
  3. 143
  4. 144

    Clinical-epidemiological and pathogenetic features of viral hepatitis C in the hemodialysis departments by R. N. Akalaev, G. Z. Aripkhodzhaeva, S. A. Rashidova, A. N. Abdullaev, K. A. Khashimov

    Published 2019-12-01
    “…With an abrupt increase in the incidence of viral hepatitis C, there is a decrease in the number of registered viral hepatitis B cases.The aim. …”
    Get full text
    Article
  5. 145

    Chronic viral hepatitis and primary liver cancer in the republic of Sakha (Yakutia) by S. S. Sleptsova, S. S. Sleptsov, M. N. Andreev, M. E. Ignatieva, L. I. Budatsyrenova

    Published 2019-12-01
    “…The materials of the official statistics of the Office of Rospotrebnadzor in the Republic of Sakha (Yakutia), the infectious disease department for treating patients with viral hepatitis of the Yakutsk Clinical Hospital were studied. …”
    Get full text
    Article
  6. 146
  7. 147

    Viral hepatitis and Parkinson disease: A national record-linkage study by Pakpoor, J, Noyce, A, Goldacre, R, Selkihova, M, Mullin, S, Schrag, A, Lees, A, Goldacre, M

    Published 2017
    “… <h4>Objective</h4> <p>To study associations between viral hepatitis and Parkinson disease (PD).</p> <h4>Methods</h4> <p>A retrospective cohort study was done by analyzing linked English National Hospital Episode Statistics and mortality data (1999–2011). …”
    Journal article
  8. 148
  9. 149
  10. 150
  11. 151
  12. 152

    Quantitative Assessment of Liver Impairment in Chronic Viral Hepatitis with [<sup>99m</sup>Tc]Tc-Mebrofenin: A Noninvasive Attempt to Stage Viral Hepatitis-Associated Liver Fibrosis by Donatas Jocius, Donatas Vajauskas, Kipras Mikelis, Skirmante Jokubauskiene, Jolita Jakutiene, Kestutis Strupas, Algirdas E. Tamosiunas

    Published 2022-09-01
    “…<i>Background and objectives</i>—Chronic viral hepatitis B and C infections are one of the leading causes of chronic liver impairment, resulting in liver fibrosis and liver cirrhosis. …”
    Get full text
    Article
  13. 153
  14. 154
  15. 155

    Clinical epidemiological and endoscopic characteristics in carriers of the viral hepatitis C with hemodialysis treatment by Mariblanca González Purón, Jesús Fernández Duharte, Daysi Martén Marén

    Published 2022-12-01
    “…Introduction: The patients with chronic renal failure in hemodialysis treatment constitute an important risk group to acquire the infection for the viral hepatitis C. Objective: To characterize carriers of the viral hepatitis C in hemodialysis treatment according to clinical epidemiological and endoscopic variables.  …”
    Get full text
    Article
  16. 156
  17. 157
  18. 158

    Clinical experience with ursodeoxycholic acid (Urdoxa) in complex therapy of chronic viral hepatitis by E. V. Esaulenko, O. E. Nikitina, N. V. Dunaeva, A. N. Uskov, T. L. Mogilevets

    Published 2014-09-01
    “…Thus, Urdoxa could be used in treatment of chronic viral hepatitis with cytolytic and cholestatic syndromes.…”
    Get full text
    Article
  19. 159

    Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development by Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger

    Published 2021-03-01
    “…Despite breakthroughs in antiviral therapies, chronic viral hepatitis B and C are still the major causes of liver fibrosis and hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  20. 160